Findings

What do systematic reviews say?

7 questions · 7 findings · 3 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 28.6%Moderate 4 · 57.1%High 1 · 14.3%

Dizziness · people with drug‐resistant focal epilepsy

1 finding from 1 review

Pregabalin add‐on for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
1.64 [0.85, 3.16]
3 studies · 1286 participants
Low

Dizziness · people with drug‐resistant focal epilepsy

Pregabalin may leads to higher adverse effect: dizziness compared with placebo (low certainty).

1 finding from 1 review

Pregabalin add‐on for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
RR 3.15 [2.23, 4.44]
7 studies · 2193 participants
Low

Dizziness · adults with moderate or severe pain associated with postherpetic neuralgia

1 finding from 1 review

Pregabalin for neuropathic pain in adults 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 732 participants
Moderate

Dizziness · adults with moderate or severe pain associated with painful diabetic neuropathy

1 finding from 1 review

Pregabalin for neuropathic pain in adults 2019 · Cochrane Headline outcomes only
no estimate extracted
12 studies · 3315 participants
Moderate

Dizziness · adults with moderate or severe pain associated with painful diabetic neuropathy

1 finding from 1 review

Pregabalin for neuropathic pain in adults 2019 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 1885 participants
Moderate

Dizziness · adults with moderate or severe pain associated with postherpetic neuralgia

1 finding from 1 review

Pregabalin for neuropathic pain in adults 2019 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 933 participants
Moderate

Dizziness · patients with fibromyalgia

Pregabalin leads to higher dizziness reported to be an adverse event compared with placebo at end of treatment (high certainty).

1 finding from 1 review

Anticonvulsants for fibromyalgia 2013 · Cochrane Headline outcomes only
RR 3.77 [3.06, 4.63]
5 studies · 3257 participants
High